Armata Pharmaceuticals (ARMP) Current Assets (2013 - 2026)

Armata Pharmaceuticals has disclosed Current Assets across 14 years of filings, most recently posting $5.9 million for Q1 2026.

• Current Assets for Q1 2026 came in at $5.9 million, down 54.84% year-over-year; the trailing twelve-month figure through Mar 2026 was $5.9 million (down 54.84% YoY), and the FY2025 annual result was $10.7 million, down 5.66% from the prior year.
• Current Assets came in at $5.9 million for Q1 2026 at Armata Pharmaceuticals, down from $10.7 million in the prior quarter.
• In the past five years, Current Assets ranged from a high of $48.7 million in Q1 2022 to a low of $5.9 million in Q1 2026.
• The 5-year median for Current Assets is $26.8 million (2023), against an average of $25.4 million.
• Across the five-year window, Current Assets surged 134.48% in 2022 and plunged 75.67% in 2025, its largest moves.
• Armata Pharmaceuticals' Current Assets stood at $27.0 million in 2022, then slipped by 29.19% to $19.2 million in 2023, then tumbled by 40.95% to $11.3 million in 2024, then fell by 5.66% to $10.7 million in 2025, then tumbled by 44.26% to $5.9 million in 2026.
• The last three Current Assets figures came in at $5.9 million (Q1 2026), $10.7 million (Q4 2025), and $16.9 million (Q3 2025), per Business Quant data.